For the third year, the FDA has slowed down its fast track approvals for new drugs with the agency offering 11 treatments with the designation in the first half of 2022.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News